Syndrome-Associated Tumors by Organ System

Raul S. Gonzalez; Nicole D. Riddle

doi:10.1055/s-0036-1580597

Journal of Pediatric Genetics, Table of Contents

J Pediatr Genet 2016; 05(02): 105-115
DOI: 10.1055/s-0036-1580597

Review Article

Georg Thieme Verlag KG Stuttgart · New York

Syndrome-Associated Tumors by Organ System

Raul S. Gonzalez

¹Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York, United States

,

Nicole D. Riddle

²Department of Pathology, Cunningham Pathology LLC, Birmingham, Alabama, United States

› Author Affiliations

Abstract

Certain tumors suggest the possibility of a patient harboring a genetic syndrome, particularly in children. Syndrome-associated tumors of the gastrointestinal tract, genitourinary tract, gynecologic tract, heart, lungs, brain, eye, endocrine organs, and hematopoietic system will be briefly discussed.

Keywords

hereditary cancer - genetics - pediatric pathology

Full Text

References

References
1 American Cancer Society. Cancer in Children. Available at: http://www.cancer.org/cancer/cancerinchildren/index . Accessed March 02, 2016
2 Schiffman JD, Geller JI, Mundt E, Means A, Means L, Means V. Update on pediatric cancer predisposition syndromes. Pediatr Blood Cancer 2013; 60 (8) 1247-1252
3 Issaivanan M, Redner A, Weinstein T , et al. Esophageal carcinoma in children and adolescents. J Pediatr Hematol Oncol 2012; 34 (1) 63-67
4 Bosman FT, Carniero F, Hruban RH, Theise ND. WHO Classification of Tumours of the Digestive System. 4th ed. Lyon, France: IARC Press; 2010
5 Chak A, Ochs-Balcom H, Falk G , et al. Familiality in Barrett's esophagus, adenocarcinoma of the esophagus, and adenocarcinoma of the gastroesophageal junction. Cancer Epidemiol Biomarkers Prev 2006; 15 (9) 1668-1673
6 Rosenberg PS, Alter BP, Ebell W. Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry. Haematologica 2008; 93 (4) 511-517
7 Akbari MR, Malekzadeh R, Lepage P , et al. Mutations in Fanconi anemia genes and the risk of esophageal cancer. Hum Genet 2011; 129 (5) 573-582
8 Robertson EV, Jankowski JA. Genetics of gastroesophageal cancer: paradigms, paradoxes, and prognostic utility. Am J Gastroenterol 2008; 103 (2) 443-449
9 Clarke CA, McCONNELL RB. Six cases of carcinoma of the oesophagus occurring in one family. BMJ 1954; 2 (4897) 1137-1138
10 de Souza CA, Santos AdaC, Santos LdaC, Carneiro AL. Hereditary tylosis syndrome and esophagus cancer [in Portuguese]. An Bras Dermatol 2009; 84 (5) 527-529
11 Subbiah V, Varadhachary G, Herzog CE, Huh WW. Gastric adenocarcinoma in children and adolescents. Pediatr Blood Cancer 2011; 57 (3) 524-527
12 Vogelaar IP, van der Post RS, Bisseling TM, van Krieken JH, Ligtenberg MJ, Hoogerbrugge N. Familial gastric cancer: detection of a hereditary cause helps to understand its etiology. Hered Cancer Clin Pract 2012; 10 (1) 18
13 Chang VY, Federman N, Martinez-Agosto J, Tatishchev SF, Nelson SF. Whole exome sequencing of pediatric gastric adenocarcinoma reveals an atypical presentation of Li-Fraumeni syndrome. Pediatr Blood Cancer 2013; 60 (4) 570-574
14 Capelle LG, Van Grieken NC, Lingsma HF , et al. Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands. Gastroenterology 2010; 138 (2) 487-492
15 Jakubowska A, Nej K, Huzarski T, Scott RJ, Lubiński J. BRCA2 gene mutations in families with aggregations of breast and stomach cancers. Br J Cancer 2002; 87 (8) 888-891
16 Hizawa K, Iida M, Yao T, Aoyagi K, Fujishima M. Juvenile polyposis of the stomach: clinicopathological features and its malignant potential. J Clin Pathol 1997; 50 (9) 771-774
17 Coffey Jr RJ, Knight Jr CD, van Heerden JA, Weiland LH. Gastric adenocarcinoma complicating Gardner's syndrome in a North American woman. Gastroenterology 1985; 88 (5 Pt 1): 1263-1266
18 Kaurah P, MacMillan A, Boyd N , et al. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA 2007; 297 (21) 2360-2372
19 Guilford P, Hopkins J, Harraway J , et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998; 392 (6674) 402-405
20 van der Post RS, Vogelaar IP, Carneiro F , et al. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. J Med Genet 2015; 52 (6) 361-374
21 Pandalai PK, Lauwers GY, Chung DC, Patel D, Yoon SS. Prophylactic total gastrectomy for individuals with germline CDH1 mutation. Surgery 2011; 149 (3) 347-355
22 Gaston D, Hansford S, Oliveira C , et al. Germline mutations in MAP3K6 are associated with familial gastric cancer. PLoS Genet 2014; 10 (10) e1004669
23 Kirmani S, Young WF. Hereditary Paraganglioma-Pheochromocytoma Syndromes. 2008 May 21 [Updated 2014 Nov 6]. In: Pagon RA, Adam MP, Ardinger HH, et al, eds. GeneReviews [Internet]. Seattle, WA: University of Washington; 1993. –2015. Available at: http://www.ncbi.nlm.nih.gov/books/NBK1548 . Accessed March 02, 2016
24 Carney JA, Stratakis CA. Familial paraganglioma and gastric stromal sarcoma: a new syndrome distinct from the Carney triad. Am J Med Genet 2002; 108 (2) 132-139
25 Miettinen M, Wang ZF, Sarlomo-Rikala M, Osuch C, Rutkowski P, Lasota J. Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age. Am J Surg Pathol 2011; 35 (11) 1712-1721
26 McWhinney SR, Pasini B, Stratakis CA ; International Carney Triad and Carney-Stratakis Syndrome Consortium. Familial gastrointestinal stromal tumors and germ-line mutations. N Engl J Med 2007; 357 (10) 1054-1056
27 Chantada GL, Perelli VB, Lombardi MG , et al. Colorectal carcinoma in children, adolescents, and young adults. J Pediatr Hematol Oncol 2005; 27 (1) 39-41
28 Hill DA, Furman WL, Billups CA , et al. Colorectal carcinoma in childhood and adolescence: a clinicopathologic review. J Clin Oncol 2007; 25 (36) 5808-5814
29 Kravarusic D, Feigin E, Dlugy E , et al. Colorectal carcinoma in childhood: a retrospective multicenter study. J Pediatr Gastroenterol Nutr 2007; 44 (2) 209-211
30 Sultan I, Rodriguez-Galindo C, El-Taani H , et al. Distinct features of colorectal cancer in children and adolescents: a population-based study of 159 cases. Cancer 2010; 116 (3) 758-765
31 Durno CA, Gallinger S. Genetic predisposition to colorectal cancer: new pieces in the pediatric puzzle. J Pediatr Gastroenterol Nutr 2006; 43 (1) 5-15
32 Jelsig AM, Qvist N, Brusgaard K, Nielsen CB, Hansen TP, Ousager LB. Hamartomatous polyposis syndromes: a review. Orphanet J Rare Dis 2014; 9: 101
33 Brosens LA, van Hattem A, Hylind LM , et al. Risk of colorectal cancer in juvenile polyposis. Gut 2007; 56 (7) 965-967
34 Jass JR, Williams CB, Bussey HJ, Morson BC. Juvenile polyposis—a precancerous condition. Histopathology 1988; 13 (6) 619-630
35 Burkart AL, Sheridan T, Lewin M, Fenton H, Ali NJ, Montgomery E. Do sporadic Peutz-Jeghers polyps exist? Experience of a large teaching hospital. Am J Surg Pathol 2007; 31 (8) 1209-1214
36 Resta N, Pierannunzio D, Lenato GM , et al; AIFEG. Cancer risk associated with STK11/LKB1 germline mutations in Peutz-Jeghers syndrome patients: results of an Italian multicenter study. Dig Liver Dis 2013; 45 (7) 606-611
37 van Lier MG, Westerman AM, Wagner A , et al. High cancer risk and increased mortality in patients with Peutz-Jeghers syndrome. Gut 2011; 60 (2) 141-147
38 Hobert JA, Eng C. PTEN hamartoma tumor syndrome: an overview. Genet Med 2009; 11 (10) 687-694
39 Stanich PP, Owens VL, Sweetser S , et al. Colonic polyposis and neoplasia in Cowden syndrome. Mayo Clin Proc 2011; 86 (6) 489-492
40 Nielsen M, Joerink-van de Beld MC, Jones N , et al. Analysis of MUTYH genotypes and colorectal phenotypes in patients With MUTYH-associated polyposis. Gastroenterology 2009; 136 (2) 471-476
41 Nielsen M, Franken PF, Reinards TH , et al. Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP). J Med Genet 2005; 42 (9) e54
42 Datta RV, LaQuaglia MP, Paty PB. Genetic and phenotypic correlates of colorectal cancer in young patients. N Engl J Med 2000; 342 (2) 137-138
43 Gonzalez RS, Shulman SC, Katzenstein HM , et al. Colorectal adenocarcinoma: a pediatric case review with a focus on mismatch repair gene mutations and E-cadherin expression. Pediatr Dev Pathol 2012; 15 (3) 192-198
44 Huang SC, Durno CA, Erdman SH. Lynch syndrome: a pediatric perspective. J Pediatr Gastroenterol Nutr 2014; 58 (2) 144-152
45 Durno C, Aronson M, Bapat B, Cohen Z, Gallinger S. Family history and molecular features of children, adolescents, and young adults with colorectal carcinoma. Gut 2005; 54 (8) 1146-1150
46 Bhaijee F, Brown AS. Muir-Torre syndrome. Arch Pathol Lab Med 2014; 138 (12) 1685-1689
47 Paraf F, Jothy S, Van Meir EG. Brain tumor-polyposis syndrome: two genetic diseases?. J Clin Oncol 1997; 15 (7) 2744-2758
48 Dipro S, Al-Otaibi F, Alzahrani A, Ulhaq A, Al Shail E. Turcot syndrome: a synchronous clinical presentation of glioblastoma multiforme and adenocarcinoma of the colon. Case Rep Oncol Med 2012; 2012: 720273
49 Wimmer K, Kratz CP. Constitutional mismatch repair-deficiency syndrome. Haematologica 2010; 95 (5) 699-701
50 Walter AW, Ennis S, Best H , et al. Constitutional mismatch repair deficiency presenting in childhood as three simultaneous malignancies. Pediatr Blood Cancer 2013; 60 (11) E135-E136
51 Yurgelun MB, Masciari S, Joshi VA , et al; Colon Cancer Family Registry. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry. JAMA Oncol 2015; 1 (2) 214-221
52 Fishman SJ, Smithers CJ, Folkman J , et al. Blue rubber bleb nevus syndrome: surgical eradication of gastrointestinal bleeding. Ann Surg 2005; 241 (3) 523-528
53 Wouters V, Limaye N, Uebelhoer M , et al. Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects. Eur J Hum Genet 2010; 18 (4) 414-420
54 Williams VC, Lucas J, Babcock MA, Gutmann DH, Korf B, Maria BL. Neurofibromatosis type 1 revisited. Pediatrics 2009; 123 (1) 124-133
55 Agaimy A, Vassos N, Croner RS. Gastrointestinal manifestations of neurofibromatosis type 1 (Recklinghausen's disease): clinicopathological spectrum with pathogenetic considerations. Int J Clin Exp Pathol 2012; 5 (9) 852-862
56 Andersson J, Sihto H, Meis-Kindblom JM, Joensuu H, Nupponen N, Kindblom LG. NF1-associated gastrointestinal stromal tumors have unique clinical, phenotypic, and genotypic characteristics. Am J Surg Pathol 2005; 29 (9) 1170-1176
57 Fendrich V, Ramaswamy A, Slater EP, Bartsch DK. Duodenal somatostatinoma associated with Von Recklinghausen's disease. J Hepatobiliary Pancreat Surg 2004; 11 (6) 417-421
58 Fuller CE, Williams GT. Gastrointestinal manifestations of type 1 neurofibromatosis (von Recklinghausen's disease). Histopathology 1991; 19 (1) 1-11
59 Pappo AS, Janeway K, Laquaglia M, Kim SY. Special considerations in pediatric gastrointestinal tumors. J Surg Oncol 2011; 104 (8) 928-932
60 Heuschkel R, Kim S, Korf B, Schneider G, Bousvaros A. Abdominal migraine in children with neurofibromatosis type 1: a case series and review of gastrointestinal involvement in NF1. J Pediatr Gastroenterol Nutr 2001; 33 (2) 149-154
61 Benesch M, Wardelmann E, Ferrari A, Brennan B, Verschuur A. Gastrointestinal stromal tumors (GIST) in children and adolescents: A comprehensive review of the current literature. Pediatr Blood Cancer 2009; 53 (7) 1171-1179
62 Beghini A, Tibiletti MG, Roversi G , et al. Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa. Cancer 2001; 92 (3) 657-662
63 Smith VV, Eng C, Milla PJ. Intestinal ganglioneuromatosis and multiple endocrine neoplasia type 2B: implications for treatment. Gut 1999; 45 (1) 143-146
64 Tiszlavicz L, Kapin M, Várkonyi A, Lõrincz A, Bartyik K, Várkonyi T. Adenocarcinoma of the colon developing on the basis of Crohn's disease in childhood. Eur J Pediatr 2001; 160 (3) 168-172
65 Herzog CE, Andrassy RJ, Eftekhari F. Childhood cancers: hepatoblastoma. Oncologist 2000; 5 (6) 445-453
66 Litten JB, Tomlinson GE. Liver tumors in children. Oncologist 2008; 13 (7) 812-820
67 DeBaun MR, Tucker MA. Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry. J Pediatr 1998; 132 (3 Pt 1) 398-400
68 Ko JM. Genetic syndromes associated with overgrowth in childhood. Ann Pediatr Endocrinol Metab 2013; 18 (3) 101-105
69 McNeil DE, Brown M, Ching A, DeBaun MR. Screening for Wilms tumor and hepatoblastoma in children with Beckwith-Wiedemann syndromes: a cost-effective model. Med Pediatr Oncol 2001; 37 (4) 349-356
70 Trobaugh-Lotrario AD, Venkatramani R, Feusner JH. Hepatoblastoma in children with Beckwith-Wiedemann syndrome: does it warrant different treatment?. J Pediatr Hematol Oncol 2014; 36 (5) 369-373
71 Walther A, Tiao G. Approach to pediatric hepatocellular carcinoma. Clin Liver Dis 2013; 2 (5) 219-222
72 Esquivel CO, Mieles L, Marino IR , et al. Liver transplantation for hereditary tyrosinemia in the presence of hepatocellular carcinoma. Transplant Proc 1989; 21 (1 Pt 2) 2445-2446
73 Franco LM, Krishnamurthy V, Bali D , et al. Hepatocellular carcinoma in glycogen storage disease type Ia: a case series. J Inherit Metab Dis 2005; 28 (2) 153-162
74 Kim B, Park SH, Yang HR, Seo JK, Kim WS, Chi JG. Hepatocellular carcinoma occurring in alagille syndrome. Pathol Res Pract 2005; 201 (1) 55-60
75 Patil MM, Patil SV. Ataxia telangiectasia with hepatocellular carcinoma. Indian Pediatr 2009; 46 (6) 546
76 Shorter NA, Glick RD, Klimstra DS, Brennan MF, Laquaglia MP. Malignant pancreatic tumors in childhood and adolescence: The Memorial Sloan-Kettering experience, 1967 to present. J Pediatr Surg 2002; 37 (6) 887-892
77 Drut R, Jones MC. Congenital pancreatoblastoma in Beckwith-Wiedemann syndrome: an emerging association. Pediatr Pathol 1988; 8 (3) 331-339
78 Larson AM, Hedgire SS, Deshpande V , et al. Pancreatic neuroendocrine tumors in patients with tuberous sclerosis complex. Clin Genet 2012; 82 (6) 558-563
79 Chun SG, Yee NS. Werner syndrome as a hereditary risk factor for exocrine pancreatic cancer: potential role of WRN in pancreatic tumorigenesis and patient-tailored therapy. Cancer Biol Ther 2010; 10 (5) 430-437
80 Vasen HF, Gruis NA, Frants RR, van Der Velden PA, Hille ET, Bergman W. Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden). Int J Cancer 2000; 87 (6) 809-811
81 Malkan AD, Loh A, Bahrami A , et al. An approach to renal masses in pediatrics. Pediatrics 2015; 135 (1) 142-158
82 Dome JS, Huff V. Wilms Tumor Overview. 2003 Dec 19 [Updated 2013 Sep 19]. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, et al, eds. GeneReviews® [Internet]. Seattle, WA: University of Washington; 1993. –2015. Available at: http://www.ncbi.nlm.nih.gov/books/NBK1294 . Accessed March 02, 2016
83 Scott RH, Stiller CA, Walker L, Rahman N. Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour. J Med Genet 2006; 43 (9) 705-715
84 Slade I, Bacchelli C, Davies H , et al. DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome. J Med Genet 2011; 48 (4) 273-278
85 Northrup H, Krueger DA ; International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 2013; 49 (4) 243-254
86 Staley BA, Vail EA, Thiele EA. Tuberous sclerosis complex: diagnostic challenges, presenting symptoms, and commonly missed signs. Pediatrics 2011; 127 (1) e117-e125
87 Eble JN. Angiomyolipoma of kidney. Semin Diagn Pathol 1998; 15 (1) 21-40
88 Kubo M, Iwashita K, Oyachi N, Oyama T, Yamamoto T. Two different types of infantile renal cell carcinomas associated with tuberous sclerosis. J Pediatr Surg 2011; 46 (10) E37-E41
89 Shepherd CW, Gomez MR, Lie JT, Crowson CS. Causes of death in patients with tuberous sclerosis. Mayo Clin Proc 1991; 66 (8) 792-796
90 Neumann HP, Zbar B. Renal cysts, renal cancer and von Hippel-Lindau disease. Kidney Int 1997; 51 (1) 16-26
91 Toro JR, Nickerson ML, Wei MH , et al. Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet 2003; 73 (1) 95-106
92 Benusiglio PR, Giraud S, Deveaux S , et al; French National Cancer Institute Inherited Predisposition to Kidney Cancer Network. Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study. Orphanet J Rare Dis 2014; 9: 163
93 Kluijt I, de Jong D, Teertstra HJ , et al. Early onset of renal cancer in a family with Birt-Hogg-Dubé syndrome. Clin Genet 2009; 75 (6) 537-543
94 Ricketts CJ, Shuch B, Vocke CD , et al. Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer. J Urol 2012; 188 (6) 2063-2071
95 Williamson SR, Eble JN, Amin MB , et al. Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma. Mod Pathol 2015; 28 (1) 80-94
96 Shuch B, Ricketts CJ, Vocke CD , et al. Germline PTEN mutation Cowden syndrome: an underappreciated form of hereditary kidney cancer. J Urol 2013; 190 (6) 1990-1998
97 Haas NB, Nathanson KL. Hereditary kidney cancer syndromes. Adv Chronic Kidney Dis 2014; 21 (1) 81-90
98 Hussein S, Satturwar S, Van der Kwast T. Young-age prostate cancer. J Clin Pathol 2015; 68 (7) 511-515
99 Raymond VM, Mukherjee B, Wang F , et al. Elevated risk of prostate cancer among men with Lynch syndrome. J Clin Oncol 2013; 31 (14) 1713-1718
100 Bujons A, Caffaratti J, Garat JM, Villavicencio H. Long-term follow-up of transitional cell carcinoma of the bladder in childhood. J Pediatr Urol 2014; 10 (1) 167-170
101 Umlauf VN, Coerdt W, Leuschner I, Schröder A, Stein R, Beetz R. How to Name Papillary Tumors of the Bladder in Children: Transitional Cell Carcinoma or Papillary Urothelial Neoplasm of Low Malignant Potential?. Urology 2015; 86 (2) 379-383 Epub ahead of print
102 Hemminki K, Bermejo JL, Ji J, Kumar R. Familial bladder cancer and the related genes. Curr Opin Urol 2011; 21 (5) 386-392
103 van der Post RS, Kiemeney LA, Ligtenberg MJ , et al. Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers. J Med Genet 2010; 47 (7) 464-470
104 Ciftci AO, Bingöl-Koloğlu M, Senocak ME, Tanyel FC, Büyükpamukçu M, Büyükpamukçu N. Testicular tumors in children. J Pediatr Surg 2001; 36 (12) 1796-1801
105 Peters JA, Vadaparampil ST, Kramer J , et al. Familial testicular cancer: interest in genetic testing among high-risk family members. Genet Med 2006; 8 (12) 760-770
106 Dieckmann KP, Rübe C, Henke RP. Association of Down's syndrome and testicular cancer. J Urol 1997; 157 (5) 1701-1704
107 Ezaki J, Hashimoto K, Asano T , et al. Gonadal tumor in Frasier syndrome: a review and classification. Cancer Prev Res (Phila) 2015; 8 (4) 271-276
108 Wang Z, Yang S, Shi H , et al. Histopathological and immunophenotypic features of testicular tumour of the adrenogenital syndrome. Histopathology 2011; 58 (7) 1013-1018
109 Risch HA, McLaughlin JR, Cole DE , et al. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst 2006; 98 (23) 1694-1706
110 Kennedy RD, Boughey JC. Management of pediatric and adolescent breast masses. Semin Plast Surg 2013; 27 (1) 19-22
111 Kaneda HJ, Mack J, Kasales CJ, Schetter S. Pediatric and adolescent breast masses: a review of pathophysiology, imaging, diagnosis, and treatment. AJR Am J Roentgenol 2013; 200 (2) W204-12
112 Brooks GA, Stopfer JE, Erlichman J, Davidson R, Nathanson KL, Domchek SM. Childhood cancer in families with and without BRCA1 or BRCA2 mutations ascertained at a high-risk breast cancer clinic. Cancer Biol Ther 2006; 5 (9) 1098-1102
113 Masciari S, Dillon DA, Rath M , et al. Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort. Breast Cancer Res Treat 2012; 133 (3) 1125-1130
114 Ahmed M, Rahman N. ATM and breast cancer susceptibility. Oncogene 2006; 25 (43) 5906-5911
115 Mester J, Eng C. Cowden syndrome: recognizing and managing a not-so-rare hereditary cancer syndrome. J Surg Oncol 2015; 111 (1) 125-130
116 Pharoah PD, Guilford P, Caldas C ; International Gastric Cancer Linkage Consortium. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 2001; 121 (6) 1348-1353
117 Stoffel E, Mukherjee B, Raymond VM , et al. Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology 2009; 137 (5) 1621-1627
118 Meyer LA, Broaddus RR, Lu KH. Endometrial cancer and Lynch syndrome: clinical and pathologic considerations. Cancer Contr 2009; 16 (1) 14-22
119 Vasen HF, Watson P, Mecklin JP , et al. The epidemiology of endometrial cancer in hereditary nonpolyposis colorectal cancer. Anticancer Res 1994; 14 (4B): 1675-1678
120 Gravholt CH, Fedder J, Naeraa RW, Müller J. Occurrence of gonadoblastoma in females with Turner syndrome and Y chromosome material: a population study. J Clin Endocrinol Metab 2000; 85 (9) 3199-3202
121 Brant WO, Rajimwale A, Lovell MA , et al. Gonadoblastoma and Turner syndrome. J Urol 2006; 175 (5) 1858-1860
122 Elnaggar AC, Spunt SL, Smith W, Depas M, Santoso JT. Endometrial cancer in a 15-year-old girl: A complication of Cowden Syndrome. Gynecol Oncol Case Rep 2012; 3: 18-19
123 Dehner LP, Jarzembowski JA, Hill DA. Embryonal rhabdomyosarcoma of the uterine cervix: a report of 14 cases and a discussion of its unusual clinicopathological associations. Mod Pathol 2012; 25 (4) 602-614
124 Vidaillet Jr HJ. Cardiac tumors associated with hereditary syndromes. Am J Cardiol 1988; 61 (15) 1355
125 Becker AE. Primary heart tumors in the pediatric age group: a review of salient pathologic features relevant for clinicians. Pediatr Cardiol 2000; 21 (4) 317-323
126 Atalay S, Aypar E, Uçar T , et al. Fetal and neonatal cardiac rhabdomyomas: clinical presentation, outcome and association with tuberous sclerosis complex. Turk J Pediatr 2010; 52 (5) 481-487
127 Bossert T, Walther T, Vondrys D, Gummert JF, Kostelka M, Mohr FW. Cardiac fibroma as an inherited manifestation of nevoid basal-cell carcinoma syndrome. Tex Heart Inst J 2006; 33 (1) 88-90
128 Correa R, Salpea P, Stratakis CA. Carney complex: an update. Eur J Endocrinol 2015; 173 (4) M85-M97
129 Priest JR, Williams GM, Manera R , et al. Ciliary body medulloepithelioma: four cases associated with pleuropulmonary blastoma—a report from the International Pleuropulmonary Blastoma Registry. Br J Ophthalmol 2011; 95 (7) 1001-1005
130 Dishop MK, Kuruvilla S. Primary and metastatic lung tumors in the pediatric population: a review and 25-year experience at a large children's hospital. Arch Pathol Lab Med 2008; 132 (7) 1079-1103
131 Hancock E, Tomkins S, Sampson J, Osborne J. Lymphangioleiomyomatosis and tuberous sclerosis. Respir Med 2002; 96 (1) 7-13
132 Stratakis CA, Carney JA. The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications. J Intern Med 2009; 266 (1) 43-52
133 Nowak DA, Trost HA, Porr A, Stölzle A, Lumenta CB. Lhermitte-Duclos disease (Dysplastic gangliocytoma of the cerebellum). Clin Neurol Neurosurg 2001; 103 (2) 105-110
134 Joly M, Valmary-Degano S, Cattin F, Vasiljevic A, Jouvet A, Viennet G. Cerebellar gangliocytoma in an 11-year-old child [in French]. Ann Pathol 2014; 34 (6) 477-480
135 Bhat S, Ming X, Dekermenjian R, Chokroverty S. Continuous spike and wave in slow-wave sleep in a patient with Rett syndrome and in a patient with Lhermitte-Duclos syndrome and neurofibromatosis 1. J Child Neurol 2014; 29 (12) NP176-NP180
136 Sévenet N, Sheridan E, Amram D, Schneider P, Handgretinger R, Delattre O. Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. Am J Hum Genet 1999; 65 (5) 1342-1348
137 Sredni ST, Tomita T. Rhabdoid tumor predisposition syndrome. Pediatr Dev Pathol 2015; 18 (1) 49-58
138 Benavente CA, Dyer MA. Genetics and epigenetics of human retinoblastoma. Annu Rev Pathol 2015; 10: 547-562
139 Knudson Jr AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971; 68 (4) 820-823
140 Blanquet V, Turleau C, Gross-Morand MS, Sénamaud-Beaufort C, Doz F, Besmond C. Spectrum of germline mutations in the RB1 gene: a study of 232 patients with hereditary and non hereditary retinoblastoma. Hum Mol Genet 1995; 4 (3) 383-388
141 Rao AA, Naheedy JH, Chen JY, Robbins SL, Ramkumar HL. A clinical update and radiologic review of pediatric orbital and ocular tumors. J Oncol 2013; 2013: 975908
142 Denayer E, Devriendt K, de Ravel T , et al. Tumor spectrum in children with Noonan syndrome and SOS1 or RAF1 mutations. Genes Chromosomes Cancer 2010; 49 (3) 242-252
143 Jongmans MC, van der Burgt I, Hoogerbrugge PM , et al. Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation. Eur J Hum Genet 2011; 19 (8) 870-874
144 Vaisman F, Corbo R, Vaisman M. Thyroid carcinoma in children and adolescents-systematic review of the literature. J Thyroid Res 2011; 2011: 845362
145 Richards ML. Familial syndromes associated with thyroid cancer in the era of personalized medicine. Thyroid 2010; 20 (7) 707-713
146 Hall JE, Abdollahian DJ, Sinard RJ. Thyroid disease associated with Cowden syndrome: A meta-analysis. Head Neck 2013; 35 (8) 1189-1194
147 Cameselle-Teijeiro J, Chan JK. Cribriform-morular variant of papillary carcinoma: a distinctive variant representing the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma?. Mod Pathol 1999; 12 (4) 400-411
148 Iwama T, Mishima Y, Utsunomiya J. The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs. Its rational treatment. Ann Surg 1993; 217 (2) 101-108
149 Fisher JP, Tweddle DA. Neonatal neuroblastoma. Semin Fetal Neonatal Med 2012; 17 (4) 207-215
150 McHugh K. Renal and adrenal tumours in children. Cancer Imaging 2007; 7: 41-51
151 Seif AE. Pediatric leukemia predisposition syndromes: clues to understanding leukemogenesis. Cancer Genet 2011; 204 (5) 227-244
152 German J. Bloom's syndrome. XX. The first 100 cancers. Cancer Genet Cytogenet 1997; 93 (1) 100-106
153 Arora H, Chacon AH, Choudhary S , et al. Bloom syndrome. Int J Dermatol 2014; 53 (7) 798-802
154 Chrzanowska KH, Gregorek H, Dembowska-Bagińska B, Kalina MA, Digweed M. Nijmegen breakage syndrome (NBS). Orphanet J Rare Dis 2012; 7: 13
155 Taylor AM, Metcalfe JA, Thick J, Mak YF. Leukemia and lymphoma in ataxia telangiectasia. Blood 1996; 87 (2) 423-438
156 Oliveira JB. The expanding spectrum of the autoimmune lymphoproliferative syndromes. Curr Opin Pediatr 2013; 25 (6) 722-729
157 Straus SE, Jaffe ES, Puck JM , et al. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood 2001; 98 (1) 194-200
158 Rabin KR, Whitlock JA. Malignancy in children with trisomy 21. Oncologist 2009; 14 (2) 164-173